NovaBay Pharma Stock Price (NYSEMKT:NBY)

Add to My Stocks
$1.35 $0 (0%) NBY stock closing price Sep 18, 2018 (Closing)
Prev Close* : $1.35
Market Cap:
Day Low: $1.3
52 Week Low: $1.25
Open: $1.3
Volume: -
Day High: $1.45
52 Week High: $4.80

Latest Stock Market News

Latest Articles

NovaBay Pharma News - From Partners

NBY Stockcharts

View NBY PE ratio, PS ratio stocks charts and compare with peers.
NBY Chart
Note: Compare NovaBay Pharma stock price history with the index and industry peers.

NovaBay Pharma Valuation

PE ratio
(price earnings ratio)
PS ratio (
price to sales ratio
PB ratio (
price to book ratio

NovaBay Pharma Returns

(return on equity)

NovaBay Pharma Financial Ratios

Asset Turnover
Receivables Turnover
Debt to Equity
Dividend Yield

NBY Industry Peers

Top Stock Gainers

show top losers
CompanyPriceChange (%)
ChemoCentryx (CCXI)11.521.03 (9.82%)
AcelRx Pharma (ACRX)3.750.3 (8.7%)
MELINTA THERAPT (MLNT)4.450.35 (8.54%)
Galectin Therapeutics (GALT)6.020.28 (4.88%)
GlycoMimetics (GLYC)14.580.67 (4.82%)
Achaogen (AKAO)4.280.17 (4.14%)
Concert Pharma (CNCE)13.420.51 (3.95%)
Top gainers from Medical-Drugs industry
* As of Sep 19, 2018
CompanyPriceChange (%)
MADRIGAL PHARMA (MDGL)207.321.13 (9.25%)
Tetraphase Pharmaceuticals (TTPH)2.90.16 (5.23%)
Recro Pharma (REPH)7.410.29 (3.77%)
Corcept Therapeutics (CORT)14.260.48 (3.26%)
Lannett Co (LCI)4.750.15 (3.06%)
Catalyst Pharma (CPRX)3.10.09 (2.82%)
Galmed Pharma (GLMD)12.610.24 (1.87%)
Top losers from Medical-Drugs industry
* As of Sep 19, 2018

NovaBay Pharmaceuticals, Inc. Stock News - Partner Headlines

NovaBay Pharma Financial Statements

income statement20172016201520142013
Net Sales or Revenues18.23M11.89M4.38M1.05M3.47M
Net Income-7.4M-13.15M-18.97M-15.19M-16.03M
Total Operating Expense22.34M20.41M24.12M17.44M18.8M
View NovaBay Pharma income statement
balance sheet20172016201520142013
Total Assets10.07M15.38M5.07M7.53M15.65M
Total Liabilities7.48M8.28M10.17M5.68M7.13M
Shareholders Equity2.59M7.1M-5.09M1.84M8.51M
View NovaBay Pharma balance sheet
cash flow statement20172016201520142013
Net Increase (Decrease) in Assets Liabilities-1.6M-3.16M1.01M--
Net Cash from (used by) Operating Activities-6.27M-12.13M-18.55M-15.05M-12.96M
Increase (Decrease) in Prop Plant And Equipment-0.24M-0.16M-0.08M--0.14M
View NovaBay Pharma cash flow statement

NovaBay Pharma Stock Message Board

As of last trading day, NovaBay Pharma stock price was $1.35. Looking at NovaBay Pharma market capitalization, which currently stands at $23.07M, we can say that NBY stock is a Nano Cap stock. NovaBay Pharma valuation can be different from its intrinsic stock price when viewed from a value investors perspective.

For recognizing and analyzing the real performance of NovaBay Pharma stock, it is a standard practise to adjust historical stock prices to remove gaps caused by stock splits, dividends and distributions. 11,077 NBY shares were traded yesterday, and NovaBay Pharma stock chart shows that the NBY stock quote hit a day high of $1.45 and day low of $1.3. Dividends are usually paid by large stable companies, and typically not by those which are in their rapid growth stages. A company's continuing success is indicated by a steadily increasing dividend payout. NovaBay Pharma dividend per share was 0.00 during the last quarter. One can observe stock price trends and check for volatility by checking NovaBay Pharma stock price history.